Association between polymorphisms in the TSHR gene and graves' orbitopathy

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Jurecka Lubieniecka, Beata ^a   Ploski, Rafal ^b   Kula, Dorota ^a   Szymanski, Konrad ^b   Bednarczuk, Tomasz ^b   Ambroziak, Urszula ^b   Hasse Lazar, Kornelia ^a   Hyla Klekot, Lidia ^c   Tukiendorf, Andrzej ^a   Kolosza, Zofia ^a   Jarzab, Barbara ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Center of Pediatrics and Oncology   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DRB1 ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; THYROTROPIN RECEPTOR;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; CTLA4 GENE; ENDOCRINE OPHTHALMOPATHY; EXON; FEMALE; GENE FREQUENCY; GENETIC ALGORITHM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HLADRB1 GENE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PTPN22 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TAXONOMY; TSHR GENE; ALLELE; GENETICS; INFLAMMATION; MIDDLE AGED; ORBIT; PATHOLOGY; RISK FACTOR;

ADULT; ALLELES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ORBIT; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, THYROTROPIN; RISK FACTORS;

EID: 84905000189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102653     Document Type: Article

References (53)

1. Iyer S, Bahn R (2012) Immunopathogenesis of Graves' orbitopathy: the role of the TSH receptor. Best Practice & Research Clin Endocrinol &Metab 26: 281-9.
2. Wiersinga WM (2011) Autoimmunity in Graves' orbitopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96(8): 2386-94.
3. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, et al (2005) Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 13(11): 1223-30.
4. Naik VM, Naik MN, Goldberg RA, Smith TJ, Douglas RS (2010) Immunopathogenesis of thyroid eye disease: emerging paradigms. Surv Ophtamol 55(3): 215-26.
5. Bahn RS (2010) Graves' orbitopathy. N Engl J Med 362: 726-38.
6. Wiersinga WM, Smit T, van der Gaag R, Koornneef L (1988) Temporal relationship between onset of Graves' orbitopathy and onset of thyroidal Graves' disease. J Endocrinol Invest 11: 615-19.
7. Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, et al (2006) Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endosrinol Metab 91(12): 4873-80. (Pubitemid 44917321)
8. Jacobson EM, Tomer Y (2007) The genetic basis of thyroid autoimmunity. Thyroid 17(10): 949-61. (Pubitemid 350071593)
9. Khalilzadeh O, Noshad S, Rashidi A, Amirzargar A (2011) Graves' orbitopathy: a review of immunogenetics. Curr Genomics 12(8): 564-75.
10. Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, et al (2000) Limited genetic susceptibility to severe Graves' orbitopathy: no role for CTLA-4 but evidence for an enviromental etiology. Thyroid 10: 791-8.
11. Krol A, Koehler A, Nowak M, Paliczka-Cieslik E, Krajewska J, et al (2014) Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy-a prospective study. Endokrynol Pol 65(1): 40-5.
12. Khalilzadeh O, Anvari M, Esteghamati A, Momen-Heravi F, Rashidi A, et al (2010) Genetic susceptibility to Graves' orbitopathy: the role of polymorphisms in anti-inflammatory cytokine genes. Ophtalmic Gen 31(4): 215-20.
13. Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, et al (2010) Genetic susceptibility to Graves' orbitopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye 24: 1058-63.
14. Lacka K, Paradowska A, Gasinska T, Soszynska J, Wichary H, et al (2009) Interleukin-1β gene (Il-1β) polymorphisms (SNP -511 and SNP +3953) in thyroid-associated orbitopathy (TAO) among the Polish population. Cur Eye Res 34: 215-20.
15. Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' orbitopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93(3): 1077-81. (Pubitemid 351398595)
16. Raychaudhuri N, Douglas RS, Smith TJ (2013) PGE2 induces Il-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated orbitopathy. PLoS ONE doi: 10.1371/journal.pone.0015296
17. Bednarczuk T, Gopinath B, Ploski R, Wall JR (2007) Susceptibility genes in Graves' orbitopathy: searching for a needle in a haystack? Clin Endocrinol 67: 3-19. (Pubitemid 46955456)
18. Kim N, Hatton MP (2008) The role of genetics in Graves' disease and thyroid orbitopathy. Seminars in Ophthalmology 23: 67-72. (Pubitemid 351156981)
19. Yin X, Latif R, Bahn R, Tomer Y, Davies TF (2008) Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' orbitopathy. Thyroid 18(11): 1201-6.
20. Yin X, Latif R, Bahn R, Davies TF (2012) Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' orbitopathy. Thyroid 22(7): 730-5.
21. Tomer Y, Menconi F, Davies TF, Barbesino G, Rocchi R, et al (2007) Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun 29: 69-77. (Pubitemid 47385112)
22. Hemminki K, Li X, Sundquist J, Sundquist K (2010) The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 34: J307-13.
23. Segni M, Wood J, Pucarelli I, Toscano V, Toscano R, et al (2001) Clustering of autoimmune thyroid diseases in children and adolescent: a study of 66 families. J Pediatr Endocrinol 14 Supl 5: 1271-5; discussion 1297-8.
24. Wiersinga WM, Bartalena L (2002) Epidemiology and prevention of Graves' orbitopathy. Thyroid 12(10): 855-60.
25. Kula D, Bednarczuk T, Jurecka-Lubieniecka B, Polanska J, Jarzab M, et al (2006) Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07. Thyroid 16(5): 447-53.
26. Bednarczuk T, Hiromatsu Y, Seki N, Płoski R, Fukutani T, et al (2004) Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' orbitopathy. Hum Immunol 65(6):632-9. (Pubitemid 38813414)
27. Jurecka-Lubieniecka B, Ploski R, Kula D, Krol A, Bednarczuk T, et al (2013) Association between age at diagnosis of Graves' disease and variants in genes involved in immune response. PLoS One 8(3):e59349. doi: 10.1371/journal.pone.0059349. Epub 2013 Mar 27.
28. Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, et al (2003) Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' orbitopathy in European and Japanese populations. Eur J Endocrinol 148(1):13-8. (Pubitemid 36175999)
29. Skorka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R, et al (2005) Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) 62(6):679-82. (Pubitemid 40825937)
30. Ploski R, Brand OJ, Jurecka-Lubieniecka B, Franaszczyk M, Kula D, et al (2010) Thyroid stimulating hormone receptor (TSHR) Intron 1 variants are major risk factors for Graves' disease inthree european caucasian cohorts. PLoS One 25;5(11):e15512. doi: 10.1371/journal.pone.0015512
31. Tukiendorf A, Kazmierski R, Michalak S (2013) The taxonomy statistic uncovers novel clinical patterns in a population of ischemic stroke patients. PLoS ONE 8(7): e69816. doi:10.1371/journal.pone.0069816
32. Sawai Y, DeGroot L (2000) Binding of human thyrotropin receptor peptides to a Graves' disease predisponsing human leukocyte antygen calss II molecule. J Clin Endocrinol Metab 85: 1176-9. (Pubitemid 32269368)
33. Brand OJ, Gough SCL (2010) Genetics and thyroid autoimmunity and the role of the TSHR. Mol Cell Endocrinol 322: 135-43.
34. Davies TF, Yin X, Latif R (2010) The genetics of the thyroid stimulating hormone receptor: history and relevance. Thyroid 20(7): 727-35.
35. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, et al. (2005) Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 90: 2898-2903. (Pubitemid 40686341)
36. Brand OJ, Barrett JC, Simmonds MJ, Newby PR CJ, McCabe CJ, et al (2009) Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum Molecular Gen 18: 1704-1713.
37. Liu BL, Yang SY, Liu W, Xue LQ, Chen X, et al (2014) Refined assotiation of TSH receptor susceptibility locus to Graves' disease in the Chines Han population. Eur J Endocrinol 170: 109-119.
38. Goldstein SM, Katowitz WR, Moshang T, Katowitz JA (2008) Pediatric thyroidassociated orbitopathy: the children's hospital of Philadelphia experience and literature review. Thyroid 18(9): 997-9.
39. Chan W, Wong GWK, Fan DSP, Cheng AC, Lam DS, et al (2002) Ophthalmopathy in childhood Graves' disease. Br J Ophthalmol 86(7): 740-2. (Pubitemid 34713158)
40. Krassas GE (2004) Treatment of juvenile Graves' disease and its ophthalmic complication: the 'European way'. Europ J Endocrinol 150: 407-14.
41. Krassas GE, Segni M, Wiersinga WM (2005) Childhood Graves' orbitopathy: results of a European questionnaire study. Eur J Endocrinol 153: 515-20. (Pubitemid 41556278)
42. Syed AA, Simmonds MJ, Brand OJ, Franklyn JA, Gough SCL, et al (2007) Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' orbitopathy. Clin Endocrinol 67: 663-7. (Pubitemid 47620429)
43. Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, et al (1999) Cytotoxic T lymphocyte antygen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitipathy. Lancet 354: 743-4. (Pubitemid 29405794)
44. Vaidya B, Oakes EJ, Imrie H, Dickinson AJ, Perros P, et al (2003) CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin Endocrinol (Oxf) 58: 732-5. (Pubitemid 36702733)
45. Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, et al (2001) MHC class II region, CTLA4 gene, and orbitopathy in patients with Graves' disease. Lancet 358: 984-5. (Pubitemid 32913527)
46. Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, et al (2003)Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' orbitopathy in European and Japanese populations. Eur J Endocrinol 148: 13-8. (Pubitemid 36175999)
47. Buzzetti R, Nistico L, Signore A, Cascino I (1999) CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy. Lancet 354: 1824.
48. Semana G, Mehra NK, Lepetit J, Horse J (1997) HLA and Graves' disease: 12th International Histocompatibility Workshop study. In Genetic Diversity of HLA Functional and Medical Implication, Medical and Scientific International Publisher, EDC, Paris, France, 1, 407.
49. Farid NR, Stone E, Johnson G (1980) Graves' disease and HLA, clinical and epidemiologic associations. Clin Endocrinol 13: 535-44. (Pubitemid 11240913)
50. Kendall-Taylor P, Stephenson A, Stratton A, Papiha SS, Perros P, et al (1988) Differentiation of autoimmune orbitopathy from Graves' hyperthyroidism by analysis of genetic markers. Clin Endocrinol 28(6): 601-10.
51. Weetman AP, So AK, Warner CA, Foroni L, Fells P, et al (1988) Immunogenetics of Graves' orbitopathy. Clin Endocrinol 28(6): 619-28.
52. Davies TF (2007) Really significant genes for autoimmune thyroid disease do not exist - so how can we predict disease. Thyroid 17: 1027-29.
53. Brix TH, Kyvik KO, Christensen K, Hegedüs L (2001) Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86(2): 930-4. (Pubitemid 32207518)